Raw Material Testing: Developing Methods for Quality Control of Phosphoramidites used in the Chemical Synthesis of Oligonucleotides

Importance of the Topic

Phosphoramidites serve as the fundamental monomers for automated chemical synthesis of oligonucleotides. Even trace-level impurities can propagate through each coupling cycle, affecting the purity and performance of the final therapeutic or diagnostic product. Reliable testing methods are therefore critical to guarantee process robustness and compliance with quality guidelines.

Objectives and Study Overview

This work aimed to develop a single, compliance-ready liquid chromatography–ultraviolet–mass spectrometry (LC-UV-MS) method for both identity confirmation and purity assessment of phosphoramidite raw materials. Using an ICH Q11 framework and acceptance criteria adapted from literature, the study evaluated method performance on representative phosphoramidites.

Methodology and Instrumentation

Sample Preparation and Conditions:

• Phosphoramidites dissolved in 0.01% triethylamine in anhydrous acetonitrile at 0.1–1.0 mg/mL.
• ACQUITY UPLC BEH C18 column (2.1 × 150 mm, 1.7 µm) operated at 24 °C.
• Mobile phases: 10 mM NH₄HCO₃ (pH 9.0) and acetonitrile; gradient run of ~55 min.

Mass Detection:

• ACQUITY QDa single-quadrupole detector in positive electrospray mode (150–1250 m/z).
• Data processed with Empower 3 CDS.

Main Results and Discussion

Identity Confirmation:

• Three phosphoramidites (dG, dA, 2′F-dA) produced two peaks each due to P-center diastereomers.
• Measured monoisotopic [M+H]⁺ masses matched calculated values within ±1 amu.

Oxidation Monitoring:

• Repeated injections from the same vial showed oxidation rising from ~1% to >5% over 40 injections.
• Separate-vial injections of 2′F-dA exhibited ~1% oxidation increase over 20 h.
• Lower analyte concentrations (0.001 mg/mL) showed up to 20% oxidation, highlighting water and concentration effects.

Assay Performance:

• Reference standard (1 mg/mL) area RSD = 0.4% with control standard recovery within 104%.
• Sensitivity standard (0.001 mg/mL) recovery at 78% met the 50–150% LOQ criterion.
• Sample purity at 0.1 mg/mL quantified at 94%, within specification.

Benefits and Practical Applications

This unified LC-UV-MS approach streamlines phosphoramidite quality control by combining identity confirmation and purity testing within a single workflow. Integration with compliance software (Empower 3) and mass confirmation via ACQUITY QDa facilitates rapid release of raw materials and supports consistent manufacturing of oligonucleotides.

Future Trends and Applications

Emerging strategies may include:

• Incorporation of in-line reducing agents or system passivation to mitigate oxidation.
• High-resolution MS for detailed impurity profiling and structural elucidation.
• Automation of sample preparation under inert atmospheres to reduce variability.
• Extension of methods to modified nucleotides and longer oligonucleotide chains.

Conclusion

A single LC-UV-MS method employing ACQUITY UPLC and QDa detection has demonstrated reliable identity and purity testing of key phosphoramidites. Controlling oxidation through sample handling and concentration selection is essential. The approach satisfies ICH-aligned criteria and can be adapted for comprehensive impurity assessment.

References

• Kulkarni JA, Witzigmann D, Thomson SB et al. The Current Landscape of Nucleic Acid Therapeutics. Nature Nanotechnology. 2021;16:630–643.
• Kiesman WF, McPherson AK, Diorazio LJ et al. Perspectives on the Designation of Oligonucleotide Starting Materials. Nucleic Acid Therapeutics. 2021;31:93–113.
• Hargreaves JS, Kaiser R, Wolber PK. The Degradation of dG Phosphoramidites in Solution. Nucleosides Nucleotides Nucleic Acids. 2015;34:691–707.
• ICH Q11: Development and Manufacture of Drug Substances. International Council for Harmonisation.